Skip to main content
OpenTrials

Clinical trial condition

Skin Manifestations

Explore clinical trials studying Skin Manifestations. Study availability and eligibility vary by location and protocol.

1,074 public trials 157 recruiting studies
Refine in advanced search Browse all conditions

Skin Manifestations trial results

Completed

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

NCT01231347

Conditions
Adenocarcinoma of the Pancreas, Advanced Malignancy, Advanced Solid Tumors, +29 more
Locations
  • Research Site Fullerton, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Los Angeles, California, United States
View all 152 locations
View Trial Details
Completed

A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501679

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Fountain Valley, California, United States
  • Galderma Investigational Site San Diego, California, United States
  • Galderma Investigational Site Washington D.C., District of Columbia, United States
  • Galderma Investigational Site Aventura, Florida, United States
View all 74 locations
View Trial Details
Completed

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

NCT04056195

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California, 1441 Eastlake Ave. Los Angeles, California, United States
  • Duke University Medical Center, 2301 Erwin Road Durham, North Carolina, United States
  • East Carolina University, 600 Moye Boulevard Greenville, North Carolina, United States
  • The Cleveland Clinic Foundation, 9500 Euclid Avenue Cleveland, Ohio, United States
View all 27 locations
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666

Conditions
Dermatitis, Neurodermatitis, Pathological Conditions, Signs and Symptoms, +8 more
Locations
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Birmingham, Alabama, United States
  • Galderma Investigational Site Los Angeles, California, United States
  • Galderma Investigational Site Sacramento, California, United States
View all 100 locations
View Trial Details
Completed

Study of the Safety and Immunogenicity of Long-term GNR-069 Therapy in ITP Patients

NCT05492409

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Health of the Russian Federation Ufa, Bashkortostan Republic, Russia
  • State Budgetary Institution of Healthcare Irkutsk awarded the "Sign of Honor" Order Regional Clinical Hospital Irkutsk, Irkutsk Oblast, Russia
  • State Budgetary Health Institution of the Kaluga Region "Kaluga Regional Clinical Hospital" Kaluga, Kaluga Oblast, Russia
  • State budgetary institution of health care of the Nizhny Novgorod region "Nizhny Novgorod Regional Clinical Hospital named after N. A. Semashko" Nizhny Novgorod, Nizhny Novgorod Oblast, Russia
View all 13 locations
View Trial Details
Completed

Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis

NCT02004041

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
Locations
  • Vanda Investigational Site Düsseldorf, Germany
  • Vanda Investigational Site Hamburg, Germany
  • Vanda Investigational Site Jena, Germany
  • Vanda Investigational Site Kiel, Germany
View Trial Details
Completed

Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

NCT03332303

Conditions
Dysuria, Hemorrhage, Lower Urinary Tract Symptoms, +9 more
Locations
  • Douglas Young, MD Sacramento, California, United States
  • Medical Center for Clinical Research San Diego, California, United States
  • Women's Health Care Research Corp. San Diego, California, United States
  • Downtown Women's Health Care Denver, Colorado, United States
View all 27 locations
View Trial Details
Completed

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

NCT03721172

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
Locations
  • Total Skin & Beauty Dermatology Center Birmingham, Alabama, United States
  • Johnson Dermatology Clinic Fort Smith, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC / Hull Dermatology Rogers, Arkansas, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 64 locations
View Trial Details

Related conditions